Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

APREA THERAPEUTICS, INC.

(APRE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2019 2020 2021 2022 2023
Capitalization1 963104107--
Entreprise Value (EV)1 83315,251,047,976,4
P/E ratio -9,83x-1,94x-2,88x-2,87x-2,74x
Yield -----
Capitalization / Revenue -----
EV / Revenue -----
EV / EBITDA -28,2x-0,29x-1,40x-1,15x-1,58x
Price to Book 7,76x1,35x2,32x2,55x8,98x
Nbr of stocks (in thousands) 20 99121 18721 187--
Reference price (USD) 45,94,925,065,065,06
Announcement Date 03/26/202003/16/2021---
1 USD in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2019 2020 2021 2022 2023
Net sales1 -----
EBITDA1 -29,5-52,8-36,5-41,7-48,3
Operating profit (EBIT)1 -29,5-52,8-38,2-43,4-50,0
Operating Margin -----
Pre-Tax Profit (EBT)1 -28,1-53,5-37,4-40,5-43,0
Net income1 -28,1-53,5-37,3-40,5-45,6
Net margin -----
EPS2 -4,67-2,53-1,75-1,76-1,85
Dividend per Share -----
Announcement Date 03/26/202003/16/2021---
1 USD in Million
2 USD
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2020 Q3 2020 Q4 2021 Q1 2021 Q2 2021 Q3 2021 Q4
Net sales1 ------
EBITDA1 -12,2-14,2-10,2-9,99-10,0-10,0
Operating profit (EBIT)1 -12,2-14,2-10,2-10,00-10,1-10,2
Operating Margin ------
Pre-Tax Profit (EBT)1 -12,3-15,4-9,67-10,3-10,0-10,1
Net income1 -12,3-15,4-9,67-10,3-10,0-10,1
Net margin ------
EPS2 -0,58-0,73-0,46-0,48-0,46-0,46
Dividend per Share ------
Announcement Date 11/05/202003/16/202105/06/202108/12/2021--
1 USD in Million
2 USD
Previous periodNext period
Balance Sheet Analysis
Fiscal Period: December 2019 2020 2021 2022 2023
Net Debt1 -----
Net Cash position1 13089,056,259,330,8
Leverage (Debt / EBITDA) 4,40x1,69x1,54x1,42x0,64x
Free Cash Flow1 -26,7-41,8-36,0-36,8-37,7
ROE (Net Profit / Equities) -77,1%-53,0%-59,7%-81,3%-140%
Shareholders' equity1 36,410162,549,832,6
ROA (Net Profit / Asset) -28,1%-47,2%-52,1%-73,6%-130%
Assets1 99,811371,755,035,0
Book Value Per Share2 5,913,652,181,990,56
Cash Flow per Share -----
Capex1 -0,0310,013,012,0
Capex / Sales -----
Announcement Date 03/26/202003/16/2021---
1 USD in Million
2 USD
Key data
Capitalization (USD) 107 205 344
Number of employees 11
Free-Float 89,9%
Free-Float capitalization (USD) 96 346 316
Avg. Exchange 20 sessions (USD) 9 781 191
Average Daily Capital Traded 9,12%
EPS & Dividend